Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA 1066, pseudogene (RNU6-1066P) is a non-coding RNA pseudogene derived from the U6 small nuclear RNA (snRNA) gene family, which is essential in the spliceosome for pre-mRNA splicing. Pseudogenes such as RNU6-1066P arise as non-functional genomic copies that resemble normal snRNA genes but typically accumulate mutations or structural changes that prevent them from producing a functional RNA product[2][3]. In general, pseudogenes like RNU6-1066P do not encode proteins or functional RNAs and are not considered drug targets, enzymes, receptors, or signaling molecules[2][3]. Some pseudogenes can generate regulatory non-coding RNAs under certain conditions, but this function has not been reported for RNU6-1066P specifically[1][2][3]. There are no known disease associations, biomarkers, drugs, or safety considerations for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 1066, pseudogene (RNU6-1066P).